Assessing the utility of home spirometry for managing children with cystic fibrosis during COVID-19 pandemic
B. Babu (Birmingham, United Kingdom), B. Heyeer (Birmingham, United Kingdom), C. Mcardle (Birmingham, United Kingdom), B. Davies (Birmingham, United Kingdom), P. Nagakumar (Birmingham, United Kingdom), M. Desai (Birmingham, United Kingdom)
Source: International Congress 2022 – Assessment and follow-up of cystic fibrosis lung disease in children
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Babu (Birmingham, United Kingdom), B. Heyeer (Birmingham, United Kingdom), C. Mcardle (Birmingham, United Kingdom), B. Davies (Birmingham, United Kingdom), P. Nagakumar (Birmingham, United Kingdom), M. Desai (Birmingham, United Kingdom). Assessing the utility of home spirometry for managing children with cystic fibrosis during COVID-19 pandemic. 2499
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|